143 related articles for article (PubMed ID: 3027585)
1. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Bönisch H; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
[TBL] [Abstract][Full Text] [Related]
2. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Zeitner CJ; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
[TBL] [Abstract][Full Text] [Related]
3. Failure of K+ to affect the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):250-4. PubMed ID: 3587371
[TBL] [Abstract][Full Text] [Related]
4. Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Oberleithner H; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):65-70. PubMed ID: 2725700
[TBL] [Abstract][Full Text] [Related]
5. Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens.
Bönisch H; Fuchs G; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):131-4. PubMed ID: 3703019
[TBL] [Abstract][Full Text] [Related]
6. The transport of (+)-amphetamine by the neuronal noradrenaline carrier.
Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):267-72. PubMed ID: 6514010
[TBL] [Abstract][Full Text] [Related]
7. The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.
Schömig E; Fischer P; Schönfeld CL; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):502-8. PubMed ID: 2559332
[TBL] [Abstract][Full Text] [Related]
8. Veratridine-induced outward transport of 3H-noradrenaline from adrenergic nerves of the rat vas deferens.
Bönisch H; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):621-30. PubMed ID: 3444479
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens.
Niebler M; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):43-9. PubMed ID: 2314482
[TBL] [Abstract][Full Text] [Related]
10. The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.
Russ H; Schömig E; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):286-96. PubMed ID: 1961255
[TBL] [Abstract][Full Text] [Related]
11. Tetrodotoxin-sensitive and -resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens.
Bönisch H; Graefe KH; Keller B
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):264-70. PubMed ID: 6664380
[TBL] [Abstract][Full Text] [Related]
12. Effect of ageing on the number of neuronal noradrenaline uptake sites in the rat vas deferens.
Markus RP; Werneck de Avellar MC
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):405-9. PubMed ID: 1436126
[TBL] [Abstract][Full Text] [Related]
13. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
Bönisch H; Harder R
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
Schömig E; Michael-Hepp J; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
[TBL] [Abstract][Full Text] [Related]
15. Sodium dependent 3H-noradrenaline release from rat neocortical slices in the absence of extracellular calcium: presynaptic modulation by mu-opioid receptor and adenylate cyclase activation.
Schoffelmeer AN; Hogenboom F; Mulder AH
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):548-52. PubMed ID: 2854212
[TBL] [Abstract][Full Text] [Related]
16. The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.
Schömig E; Schönfeld CL; Halbrügge T; Graefe KH; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):160-70. PubMed ID: 2234101
[TBL] [Abstract][Full Text] [Related]
17. Release of 3H-noradrenaline from the rat vas deferens under various in vitro conditions.
Ross SB; Kelder D
Acta Physiol Scand; 1979 Mar; 105(3):338-49. PubMed ID: 443064
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.
Azevedo I; Moura D; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):245-8. PubMed ID: 2234107
[TBL] [Abstract][Full Text] [Related]
19. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.
Carlsson L; Graefe KH; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):508-18. PubMed ID: 3437922
[TBL] [Abstract][Full Text] [Related]
20. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
Bryan-Lluka LJ; Seers H; Sharpe I
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
